Peter Savas, Chairman and CEO of Boston Life Sciences, Inc., Scheduled to Appear on New England Cable News 'New England Busines
30 Août 2006 - 5:10PM
PR Newswire (US)
HOPKINTON, Mass., Aug. 30 /PRNewswire-FirstCall/ -- Boston Life
Sciences, Inc. (NASDAQ:BLSI), a biotechnology company focused on
diagnostic and therapeutic products for diseases of the Central
Nervous System (CNS), today announced that Peter G. Savas, Chairman
and CEO, is scheduled to be interviewed this evening on New England
Cable News "New England Business Today." The program is scheduled
to air at 6:30 PM EDT on local New England cable networks. All
"Business Day" interviews are posted on the NECN website,
http://www.necn.com/. About New England Business Day Anchors R.D.
Sahl, Beth Shelburne and Myriam Wright examine the state of the
markets, news of New England businesses and the local economy.
Personal finance, investing, consumer news, advertising, mutual
funds, the web, high technology, biotechnology, emerging
industries, and established New England companies will all be
examined in the larger context of the national and international
economic landscapes About Boston Life Sciences Boston Life
Sciences, Inc. (BLSI) is engaged in the research and clinical
development of diagnostic and therapeutic products for central
nervous system (CNS) disorders. ALTROPANE(R) molecular imaging
agent is in Phase III clinical trials for the diagnosis of
Parkinsonian Syndrome (PS) and in Phase II clinical trials for the
diagnosis of Attention Deficit Hyperactivity Disorder (ADHD). The
Company's research and pre-clinical CNS programs include INOSINE
for the treatment of stroke, a DAT blocker for the treatment of
Parkinson's disease and a second generation technetium-based
molecular imaging agent for PS and ADHD. BLSI's current research
collaborations include Harvard Medical School and Children's
Hospital Boston. Contact: Sharon Correia -- 508-497-2360 ext 224
Boston Life Sciences, Inc. DATASOURCE: Boston Life Sciences, Inc.
CONTACT: Sharon Correia, +1-508-497-2360, ext. 224 of Boston Life
Sciences, Inc., Web site: http://www.bostonlifesciences.com/
http://www.necn.com/
Copyright
Boston Life Sciences (NASDAQ:BLSI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Boston Life Sciences (NASDAQ:BLSI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Boston Life Sciences (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Boston Life Sciences (MM)